Market Cap 380.23M
Revenue (ttm) 0.00
Net Income (ttm) -129.47M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.01
Volume 432,600
Avg Vol 621,896
Day's Range N/A - N/A
Shares Out 68.63M
Stochastic %K 80%
Beta 1.92
Analysts Strong Sell
Price Target $25.00

Company Profile

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company's lead product candidate is palazestrant, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; OPERA-01, the pivota...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 651 3316
Website: olema.com
Address:
780 Brannan Street, San Francisco, United States
johsmith
johsmith Aug. 20 at 9:22 PM
$OLMA trading basically at cash value. Company for free with very promising catalysts on the horizon. Very interesting.
0 · Reply
justiceforb_85
justiceforb_85 Aug. 19 at 10:56 PM
$OLMA bit of a catalyst desert here but think patience will pay off when palazestrant is likely the best-in-class SERD.
0 · Reply
elmono
elmono Aug. 19 at 3:17 PM
$XBI best small caps down 5%…XBI down only 1.3%….market manipulation. $LRMR $AQST $KURA $OLMA ….I hate this market so much 😁
1 · Reply
traderhr
traderhr Aug. 16 at 12:52 PM
The chart displays a series of upward movements in price, particularly noticeable in the last few months. The stock has recently crossed above the moving average, suggesting strengthening $OLMA #tradeideas #swingtrading $SPX https://www.traderhr.com/charts-to-watch-olea/
0 · Reply
JarvisFlow
JarvisFlow Aug. 14 at 3:36 PM
JP Morgan updates rating for Olema Pharmaceuticals ( $OLMA ) to Overweight, target set at 28 → 29.
0 · Reply
justiceforb_85
justiceforb_85 Aug. 13 at 1:10 AM
$OLMA awesome movement!
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 11:30 AM
Citigroup has updated their rating for Olema Pharmaceuticals ( $OLMA ) to Buy with a price target of 21.
0 · Reply
Filvul
Filvul Aug. 11 at 2:02 PM
0 · Reply
justiceforb_85
justiceforb_85 Aug. 5 at 3:41 AM
$OLMA this is a long-term hold. Palazestrant with evidence of activity in ESR1-WT BC where other SERDs have been ineffective.
1 · Reply
Filvul
Filvul Jul. 31 at 3:29 PM
$OLMA give us 6$:)
0 · Reply
Latest News on OLMA
Olema Oncology Appoints Shawnte M. Mitchell, J.D.

Feb 18, 2025, 7:00 AM EST - 6 months ago

Olema Oncology Appoints Shawnte M. Mitchell, J.D.


Top 3 Health Care Stocks That May Explode In Q4

Dec 18, 2024, 7:46 AM EST - 8 months ago

Top 3 Health Care Stocks That May Explode In Q4

MODV SLN


Olema Pharmaceuticals: Advancing On Multiple Fronts

Nov 28, 2023, 11:52 AM EST - 1 year ago

Olema Pharmaceuticals: Advancing On Multiple Fronts


Olema: Two-Pronged Approach To Treat Breast Cancer Patients

Sep 18, 2023, 3:20 PM EDT - 2 years ago

Olema: Two-Pronged Approach To Treat Breast Cancer Patients


Olema Oncology: Best Contrarian Oncology Play For 2023

May 19, 2023, 4:30 PM EDT - 2 years ago

Olema Oncology: Best Contrarian Oncology Play For 2023


johsmith
johsmith Aug. 20 at 9:22 PM
$OLMA trading basically at cash value. Company for free with very promising catalysts on the horizon. Very interesting.
0 · Reply
justiceforb_85
justiceforb_85 Aug. 19 at 10:56 PM
$OLMA bit of a catalyst desert here but think patience will pay off when palazestrant is likely the best-in-class SERD.
0 · Reply
elmono
elmono Aug. 19 at 3:17 PM
$XBI best small caps down 5%…XBI down only 1.3%….market manipulation. $LRMR $AQST $KURA $OLMA ….I hate this market so much 😁
1 · Reply
traderhr
traderhr Aug. 16 at 12:52 PM
The chart displays a series of upward movements in price, particularly noticeable in the last few months. The stock has recently crossed above the moving average, suggesting strengthening $OLMA #tradeideas #swingtrading $SPX https://www.traderhr.com/charts-to-watch-olea/
0 · Reply
JarvisFlow
JarvisFlow Aug. 14 at 3:36 PM
JP Morgan updates rating for Olema Pharmaceuticals ( $OLMA ) to Overweight, target set at 28 → 29.
0 · Reply
justiceforb_85
justiceforb_85 Aug. 13 at 1:10 AM
$OLMA awesome movement!
0 · Reply
JarvisFlow
JarvisFlow Aug. 12 at 11:30 AM
Citigroup has updated their rating for Olema Pharmaceuticals ( $OLMA ) to Buy with a price target of 21.
0 · Reply
Filvul
Filvul Aug. 11 at 2:02 PM
0 · Reply
justiceforb_85
justiceforb_85 Aug. 5 at 3:41 AM
$OLMA this is a long-term hold. Palazestrant with evidence of activity in ESR1-WT BC where other SERDs have been ineffective.
1 · Reply
Filvul
Filvul Jul. 31 at 3:29 PM
$OLMA give us 6$:)
0 · Reply
CerealDefense
CerealDefense Jul. 30 at 7:33 PM
$OLMA 🙄 just take all gains…sure, why not
0 · Reply
StardustTrader
StardustTrader Jul. 30 at 5:43 PM
$OLMA still the sweet spot for adds. But, not sure we will see them again
0 · Reply
justiceforb_85
justiceforb_85 Jul. 30 at 3:59 PM
$OLMA after moves with $CELC the data for palazestrant should be game-changing.
0 · Reply
CerealDefense
CerealDefense Jul. 30 at 3:34 AM
$OLMA can this finally stay over $5? Felt very undervalued at $3-4 especially looking at the company valuation.
0 · Reply
Filvul
Filvul Jul. 3 at 2:31 PM
0 · Reply
Winning_calls
Winning_calls Jun. 30 at 1:33 PM
$OLMA 😗😗
0 · Reply
Winning_calls
Winning_calls Jun. 30 at 3:51 AM
$OLMA pick me up @ $4.50
0 · Reply
4_4
4_4 Jun. 27 at 5:16 PM
$OLMA Buyout for Palazestrant would be nice. $NVS ? Probably jumping to conclusions before PFS info is out.
0 · Reply
justiceforb_85
justiceforb_85 Jun. 26 at 8:11 PM
$OLMA look forward to future updates of palazestrant.
0 · Reply
StardustTrader
StardustTrader Jun. 17 at 9:41 PM
$OLMA adding a bit more
0 · Reply
JimCramerisadoofus
JimCramerisadoofus Jun. 12 at 1:36 PM
$OLMA Buy the dip!
0 · Reply
StardustTrader
StardustTrader Jun. 10 at 4:36 PM
$OLMA this is the zone. Averaging up a smidge.
0 · Reply